Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 7, Issue 6 (2018)

Diagnostic evaluation and therapeutic management of dilated cardiomyopathy (DCM) in a Labrador retriever

Author(s):
Saahithya Rajamohan, Harish Lompiyan Janarthanan, M Chandrasekar and K Jeyaraja
Abstract:
A male Labrador retriever of 9 years of age was presented with severe abdominal distension, exercise intolerance and inappetance. On physical examination, tachycardia, weak femoral pulse, fluid thrill on percussion of distended abdomen and dyspnoea were appreciated. Electrocardiography showed atrial fibrillation. In radiograph, cardiomegaly was noticed and vertebral heart score of 12 was measured. Echocardiography was performed.
The dog was diagnosed with Dilated cardiomyopathy. For long time support, it was treated with Pimobendan @ 0.25mg/kg b.wt BID P/O, Diltiazem, a calcium channel blocker @ 2mg/kg b.wt TID P/O along with enalapril maleate @ 0.5mg/kg b.wt and furosemide @ 1.5mg/kg b.wt. The owner was further informed that the treatment was to prolong the life span of dog with better quality of life.
Pages: 509-511  |  245 Views  4 Downloads
How to cite this article:
Saahithya Rajamohan, Harish Lompiyan Janarthanan, M Chandrasekar, K Jeyaraja. Diagnostic evaluation and therapeutic management of dilated cardiomyopathy (DCM) in a Labrador retriever. Pharma Innovation 2018;7(6):509-511.
The Pharma Innovation Journal